Insulin-like Growth Factor (IGF)-I, IGF-II, IGF Binding Protein-3, and Risk of Colorectal Cancer: A Nested Casecontrol Study in the JACC Study

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue SUPPL.1, 2009, Pages 45-50

  Suzuki, Sadao ^a   Kojima, Masayo ^a   Tokudome, Shinkan ^b   Suzuki, Koji ^c   Ozasa, Kotaro ^d,h   Ito, Yoshinori ^e   Inaba, Yutaka ^f   Tajima, Kazuo ^g   Nakachi, Kei ^d   Watanabe, Yoshiyuki ^h,v   Tamakoshi, Akiko ⁱ   Mori, Mitsuru ^j   Sakauchi, Fumio ^j   Motohashi, Yutaka ^k   Tsuji, Ichiro ^l   Nakamura, Yosikazu ^m   Iso, Hiroyasu ⁿ   Mikami, Haruo ^o   Kurosawa, Michiko ^p   Hoshiyama, Yoshiharu ^q   Tanabe, Naohito ^r   Tamakoshi, Koji ^s   Wakai, Kenji ^e   Hashimoto, Shuji ^b   Kikuchi, Shogo ^t   Wada, Yasuhiko ⁱ   Kawamura, Takashi ^u   Miki, Tsuneharu ^d   Date, Chigusa ^w   Sakata, Kiyomi ^x   Kurozawa, Yoichi ^y   Yoshimura, Takesumi ^z   Fujino, Yoshihisa ^aa   Shibata, Akira ^ab   Okamoto, Naoyuki ^ac   Shio, Hideo ^ad   more..

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JISSEN WOMEN'S UNIVERSITY   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

^h KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

ⁱ AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m JICHI MEDICAL UNIVERSITY   (Japan)

ⁿ OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^o CHIBA CANCER CENTER   (Japan)

^p JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q UNIVERSITY OF HUMAN ARTS AND SCIENCES   (Japan)

^r NIIGATA UNIVERSITY   (Japan)

^s NAGOYA UNIVERSITY   (Japan)

^t FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u KANSAI ROSAI HOSPITAL   (Japan)

^v KYOTO UNIVERSITY   (Japan)

^w NARA WOMEN'S UNIVERSITY   (Japan)

^x IWATE MEDICAL UNIVERSITY   (Japan)

^y TOTTORI UNIVERSITY   (Japan)

^z FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^aa UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^ab KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ac KANAGAWA CANCER CENTER   (Japan)

^ad Moriyama Municipal Hospital   (Japan)

more..

Author keywords

Colorectal cancer; IGF I II; IGFBP 3; Japan collaborative cohort study; Nested case control study

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; RISK; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77957338998     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Firth SM, Baxter RC (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev, 23, 824-54.
2. Giovannucci E (1999) Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res, 51 Suppl 3, 34-41.
3. Giovannucci E, Pollak MN, Platz EA, et al (2000). A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev, 9, 345-9.
4. Ito Y, Nakachi K, Imai K, Hashimoto S, et al (2005). Stability of frozen serum levels of insulin-like growth factor-I, insulinlike growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol, 15 Suppl 1, S67-73.
5. Jones JI, Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev, 16, 3-34.
6. Kaaks R, Toniolo P, Akhmedkhanov A, et al (2000). Serum Cpeptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst, 92, 1592-600.
7. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000). The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev, 21, 215-44.
8. Ma J, Giovannucci E, Pollak M, Stampfer M (1999a). RESPONSE: Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst, 91, 2052.
9. Ma J, Pollak MN, Giovannucci E, et al (1999b). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.J Natl Cancer Inst, 91, 620-5.
10. Morris JK, George LM, Wu T, Wald NJ (2006). Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies. Br J Cancer, 95, 112-7.
11. Nomura AM, Stemmermann GN, Lee J, Pollak MN (2003). Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men. Am J Epidemiol, 158, 424-31.
12. Ohno Y., Tamakoshi A (2001). Japan collaborative cohort study for evaluation of cancer risk sponsored by monbusho (JACC study). J Epidemiol, 11, 144-50.
13. Palmqvist R, Hallmans G, Rinaldi S, et al (2002). Plasma insulinlike growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut, 50, 642-6.
14. Probst-Hensch, NM, Yuan JM, Stanczyk FZ, et al (2001). IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer, 85, 1695-9.
15. Rajaram S, Baylink DJ, Mohan S (1997). Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev, 18, 801-31.
16. Renehan AG, Zwahlen M, Minder C, et al (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 363, 1346-53.
17. Suzuki S, Kawado M, Hashimoto S, et al (2005). Change in food intake frequency at five years after baseline in the JACC study. J Epidemiol, 15 Suppl 1, S48-55.
18. Takata Y, Maskarinec G, Rinaldi S, Kaaks R, Nagata C (2006). Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake. Nutr Cancer, 56, 136-42.
19. Tamakoshi A, Yoshimura T, Inaba Y, et al (2005). Profile of the JACC study. J Epidemiol, 15 Suppl 1, S4-8.